ReportsIMMUNOTHERAPY

Tumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes

See allHide authors and affiliations

Science Immunology  21 Feb 2020:
Vol. 5, Issue 44, eaaz3199
DOI: 10.1126/sciimmunol.aaz3199

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Immunology

Navigate This Article